Alzheimer's Disease News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–10 of 10 articles
Biogen and Eisai expand Leqembi access with subcutaneous maintenance dosing
Roche reports positive Phase 3 results for trontinemab in Alzheimer's disease
Eli Lilly's donanemab wins FDA approval for early Alzheimer's disease
AC Immune Advances ACI-24 Alzheimer's Trial to Final Cohort, Initiates ACI-19764 Phase 1 Study
AC Immune Initiates Final Cohort in Phase 1b/2 ABATE Trial for Anti-Abeta Alzheimer's Treatment
FDA Approves Synapton: Breakthrough for Severe Alzheimer's Treatment
Re:Cognition Health Launches International Clinical Trial for Revolutionary Finger-Prick Alzheimer's Blood Test
Nexalin Technology Advances FDA Strategy for Alzheimer's Treatment Following U.S. and China Leadership Meetings
FDA Approves CogniMax: New Early-Stage Alzheimer's Treatment
FDA Grants Accelerated Approval to Eli Lilly's Donanemab for Alzheimer's